Key Trends Reshaping the Anti-Inflammatory Drugs Market: Improving Patient Compliance Through Topical Anti-Inflammatory Solutions Enhancing Patient Compliance Through Localized Drug Delivery Industry Transformation

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Anti-Inflammatory Drugs Market Size Growth Forecast: What to Expect by 2025?
The market size for anti-inflammatory drugs has seen a swift upward trajectory in the recent past. The market is projected to increase from $136.86 billion in 2024 to $152.08 billion in 2025, representing a compound annual growth rate (CAGR) of 11.1%. Various factors such as an aging population, increased prevalence of chronic inflammatory diseases, wider over-the-counter availability, heightened consciousness regarding pain management, and growth in healthcare infrastructure have contributed to this surge in the historical period.

How Will the Anti-Inflammatory Drugs Market Size Evolve and Grow by 2029?
The market size for anti-inflammatory drugs is predicted to achieve significant growth in the upcoming years, reaching $228.83 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 10.8%. This projected growth during the forecast period is primarily due to the rise in the occurrence of autoimmune diseases, the escalating demand for individualized medicine, an expanding elderly population, encouraging government initiatives, and an increasing preference for topical and targeted treatments. Notable trends during the forecast period encompass biological drug breakthroughs, a shift towards biologics and biosimilars, telemedicine prescriptions, the application of AI in drug discovery, and research and development in new anti-inflammatory mechanisms and advancements in targeted anti-inflammatory therapies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/anti-inflammatory-drugs-global-market-report

What Drivers Are Propelling the Growth of Anti-Inflammatory Drugs Market Forward?
With the growing occurrence of arthritis, it is predicted that the expansion of the anti-inflammatory drugs market will be invigorated. Arthritis, which triggers inflammation in one or more joints leading to swelling, stiffness, and pain that can intensify with age, has its prevalence mainly due to the ageing population. As people age, the natural deterioration of joints escalates and the chances of acquiring arthritis increase. Anti-inflammatory drugs are beneficial as they decrease inflammation and pain in joints, enabling patients to retain better mobility and carry out day-to-day activities with fewer difficulties, consequently enhancing their general quality of life. For instance, the Office for Health Improvement and Disparities, a UK government department, reported in March 2023 that in 2022, the proportion of individuals 16 years and over with a long-term musculoskeletal (MSK) condition, like arthritis or chronic back or joint issue, went up to 17.6% from 17.0% in 2021. Hence, the escalating occurrence of arthritis is propelling the growth of the anti-inflammatory drugs market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24465&type=smp

Which Emerging Trends Are Transforming the Anti-Inflammatory Drugs Market in 2025?
In order to improve targeted delivery and patient adherence, key players in the anti-inflammatory drug market are keen on designing novel formulations, such as topical solutions. These are liquid therapeutics directly administered on skin or the affected area. They aid anti-inflammatory medicines by delivering active ingredients locally, thereby mitigating inflammation on-site and reducing potential systemic side effects. As an example, Lupin Limited, a pharmaceutical enterprise based in India, introduced the authorized generic variant of Horizon Pharma Therapeutics' PENNSAID (Diclofenac Sodium Topical Solution, 2% w/w) in the U.S. in December 2022. The introduction aimed at widening its portfolio of U.S. generics and promoting access to economical anti-inflammatory cures. The medicine, a nonsteroidal anti-inflammatory drug, is employed to manage pain associated with osteoarthritis of the knee, yielding local relief through topical administration, and reducing systemic side effects often observed with oral NSAIDs.

What Are the Key Segments in the Anti-Inflammatory Drugs Market?
The anti-inflammatory drugs market covered in this report is segmented -

1) By Drug Class: Steroids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Biologics And Biosimilars, Other Drug Classes
2) By Route of Administration: Parenteral, Oral, Topical, Inhalation
3) By Applications: Autoimmune Diseases, Respiratory Diseases, Other Diseases
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Steroids: Corticosteroids, Mineralocorticoids
2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Selective Cyclooxygenase-2 (COX-2) Inhibitors
3) By Biologics And Biosimilars: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin (IL) Inhibitors, Janus Kinase (JAK) Inhibitors, Other Biologics And Biosimilars
4) By Other Drug Classes: Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants, Antihistamines

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24465&type=smp

Who Are the Key Players Shaping the Anti-Inflammatory Drugs Market's Competitive Landscape?
Major companies operating in the anti-inflammatory drugs market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited

What Geographic Markets Are Powering Growth in the Anti-Inflammatory Drugs Market?
North America was the largest region in the anti-inflammatory drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24465

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.